The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors.
作者信息
von Angerer E, Prekajac J, Schneider M R, Berger M R
出版信息
J Cancer Res Clin Oncol. 1985;110(3):216-20. doi: 10.1007/BF00399276.
Abstract
The antineoplastic activity of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) was determined in several estrogen-dependent mammary tumor models. The growth of DMBA-induced rat mammary carcinomas was inhibited by doses ranging from 2 to 18 mg/kg. A dose of 6 X 12 mg/kg per week p.o. reduced the tumor area by 82% (control + 192%). D 15413 was also active against MNU-induced rat mammary tumors and transplanted MXT tumors of the mouse. In vitro, the growth of estrogen receptor positive MCF-7 breast cancer cells was inhibited by D 15413 (10(-8) - 10(-5) M). A mode of action considering endocrine and cytotoxic effects is discussed.
摘要
相似文献
1
The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors.
J Cancer Res Clin Oncol. 1985;110(3):216-20. doi: 10.1007/BF00399276.
2
Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.抗孕激素奥那司酮与抗雌激素ICI 164384联合使用可增强其抗肿瘤疗效。
J Cancer Res Clin Oncol. 1994;120(5):298-302. doi: 10.1007/BF01236387.
3
[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.[水合-1-(2,6-二氯-4-羟基苯基)-2-苯乙二胺]硫酸铂(II)配合物，其2-苯环上具有可变取代基。3. 乳腺癌抑制特性研究。
J Cancer Res Clin Oncol. 2000 Nov;126(11):647-54. doi: 10.1007/s004320000149.
4
Chlorocarbamate-mustard-linked 1,1,2-triphenylbut-1-enes with a selective antitumor activity on mammary tumors containing estrogen receptors.与氯代氨基甲酸酯相连的1,1,2-三苯基丁-1-烯对含有雌激素受体的乳腺肿瘤具有选择性抗肿瘤活性。
J Cancer Res Clin Oncol. 1988;114(6):583-7. doi: 10.1007/BF00398181.
5
Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone.用西曲瑞克（SB - 75）治疗实验性二甲基苯并蒽诱导的乳腺癌：一种促黄体生成素释放激素的强效拮抗剂。
J Cancer Res Clin Oncol. 1992;118(1):44-9. doi: 10.1007/BF01192310.
6
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer.[内消旋-1,2-双(2,6-二氯-4-羟基苯基)乙二胺]-二氯铂(II)，一种不仅在乳腺癌和前列腺癌治疗中具有肠胃外活性还具有口服活性的新药。
J Cancer Res Clin Oncol. 1993;119(12):707-16. doi: 10.1007/BF01195341.
7
The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors.5-乙酰氧基-2-(4-乙酰氧基苯基)-1-乙基-3-甲基吲哚（D 16726）对雌激素依赖性乳腺肿瘤的抑制作用。
Eur J Cancer Clin Oncol. 1985 Apr;21(4):531-7. doi: 10.1016/0277-5379(85)90048-3.
8
Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours.康士得（ICI 176.334）在激素依赖性肿瘤中的抗增殖活性。
J Cancer Res Clin Oncol. 1993;119(11):669-74. doi: 10.1007/BF01215986.
9
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the rat.3,4-双（3'-羟基苯基）己烷——一种新型乳腺肿瘤抑制化合物。对大鼠二甲基苯并蒽诱导的激素依赖性乳腺肿瘤作用机制的研究。
J Cancer Res Clin Oncol. 1982;103(3):241-54. doi: 10.1007/BF00409700.
10
Cytotoxic esters of 1,1-bis-(4-hydroxyphenyl)-2-phenyl-but-1-ene with selective antitumor activity against estrogen receptor-containing mammary tumors.1,1-双-（4-羟基苯基）-2-苯基-1-丁烯的具有对含雌激素受体的乳腺肿瘤选择性抗肿瘤活性的细胞毒性酯类
J Cancer Res Clin Oncol. 1987;113(3):230-4. doi: 10.1007/BF00396378.
本文引用的文献
1
The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer.晚期乳腺癌雌激素受体阳性无反应患者的问题。
Cancer. 1980 Dec 15;46(12 Suppl):2835-7. doi: 10.1002/1097-0142(19801215)46:12+<2835::aid-cncr2820461420>3.0.co;2-m.
2
Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice.他莫昔芬、三苯氧胺及一种新型雌激素拮抗剂（LY117018）在大鼠和小鼠中的子宫生物测定
Life Sci. 1980 Apr 28;26(17):1453-8. doi: 10.1016/0024-3205(80)90049-1.
3
4
Antiestrogenic effects of LY 117018 in MCF-7 cells.
Endocrinology. 1983 Aug;113(2):611-7. doi: 10.1210/endo-113-2-611.
5
Proliferative pattern of uterine cells from birth to adulthood in intact, neonatally castrated, and/or adrenalectomized mice, assayed by incorporation of [125I]iododeoxyuridine.通过掺入[125I]碘脱氧尿苷对完整、新生期去势和/或肾上腺切除小鼠从出生到成年期子宫细胞的增殖模式进行检测。
Endocrinology. 1983 Aug;113(2):582-7. doi: 10.1210/endo-113-2-582.
6
Development of new drugs for endocrine tumour chemotherapy.内分泌肿瘤化疗新药的研发。
Cancer Treat Rev. 1984 Mar;11 Suppl A:147-53. doi: 10.1016/0305-7372(84)90054-9.
7
2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat.2-苯基吲哚。大鼠体内结构、雌激素受体亲和力与乳腺肿瘤抑制活性之间的关系。
J Med Chem. 1984 Nov;27(11):1439-47. doi: 10.1021/jm00377a011.
8
2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds.2-（羟基苯基）吲哚：一类新型的乳腺肿瘤抑制化合物。
J Med Chem. 1983 Jan;26(1):113-6. doi: 10.1021/jm00355a024.
9
Influence of oxygen and culture media on plating efficiency of some mammalian tissue cells.氧气和培养基对某些哺乳动物组织细胞接种效率的影响。
J Natl Cancer Inst. 1972 Dec;49(6):1705-12. doi: 10.1093/jnci/49.6.1705.
10
The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors.5-乙酰氧基-2-(4-乙酰氧基苯基)-1-乙基-3-甲基吲哚（D 16726）对雌激素依赖性乳腺肿瘤的抑制作用。
Eur J Cancer Clin Oncol. 1985 Apr;21(4):531-7. doi: 10.1016/0277-5379(85)90048-3.
Zotero 插件